Standardized Uptake Value as an Unreliable Index of Renal Disease on Fluorodeoxyglucose PET Imaging
- 1 May 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 25 (5) , 358-360
- https://doi.org/10.1097/00003072-200005000-00008
Abstract
Fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography has been used extensively in the diagnosis of malignant conditions with high rates of sensitivity and specificity. However, increased FDG uptake is not limited to malignant tissue. In general, lesions with a mild degree of FDG uptake as measured by standardized uptake values less than 2.0 are considered benign, whereas those with values greater than 2.5 are usually regarded as malignant. Standardized uptake values in the kidney can be as high as 22 as a result of excretion of FDG through urine. Two cases are reported in which renal abnormalities could not be distinguished from urine based on standard uptake values alone.Keywords
This publication has 6 references indexed in Scilit:
- Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- FDG PET diagnosis of septic kidney in a renal transplant patientTransplant International, 1999
- Differentiating Benign from Malignant Lung Lesions Using “Quantitative” Parameters of FDG PET ImagesClinical Nuclear Medicine, 1996
- Singles transmission in volume-imaging PET with a137Cs sourcePhysics in Medicine & Biology, 1995
- Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda.Radiology, 1994
- Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Radiology, 1993